Jorge Belardi2011-08-05
CABG vs. PCI for LM Disease: do we Need a New Randomized Trial?. The Rationale for EXCEL Trial
Alfredo E. Rodriguez 2012-08-10
Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Ashok Seth 2012-08-10
Enfermedad multivaso DES for multivessel PCI
Ajay Kirtane2011-08-04
Efficacy of intracoronary IIb/IIIa inhibitor during primary PCI. Standard use or bailout only?
Costantino R. Costantini 2012-08-09
Patient Characteristics and PCI Strategies: How They Impinge on the Current Incidence of Coronary Restenosis
José Luis Leiva Pons 2012-08-08
Now that We Have Choices, which Antiplatelet Drug (and dosage) Is Preferred Prior to PCI in the Elective, the Ad Hoc and the ACS Patient?
Alejandro MartÃnez Sepúlveda 2012-08-08
PCI vs. CABG in patients aged under 50 years
Original title: Comparison of 30-Day and 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Bypass Grafting in Patients Aged ≤50 Years. Reference: Fausto Biancari, et al. Am J Cardiology Article in Press. Coronary artery bypass grafting (CABG) is associated with better evolution than percutaneous coronary intervention (PCI), mainly due to left main and multiple vessels re...
PCI with everolimus eluting stent or CABG for multivessel coronary artery disease.
Original title: Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease. Reference: Sripal Bangalore, M.D. et al. N Engl J Med. 2015 Mar 26;372(13):1213-22. Coronary artery bypass grafting (CABG) have had better outcomes than percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease. However, this information comes from studies that do not include new generation stents....